Detalhe da pesquisa
1.
Exploring olfactory receptor family 7 subfamily C member 1 as a novel oral cancer stem cell target for immunotherapy.
Cancer Sci
; 114(9): 3496-3508, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344992
2.
Prognostic value of HLA class I expression in patients with oral squamous cell carcinoma.
Cancer Sci
; 111(5): 1491-1499, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167621
3.
Notch signaling genes and CD8+ T-cell dynamics: Their contribution to immune-checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study.
Cancer Med
; 13(5): e6985, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491819
4.
Cisplatin-induced HSF1-HSP90 axis enhances the expression of functional PD-L1 in oral squamous cell carcinoma.
Cancer Med
; 12(4): 4605-4615, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200687
5.
Three-Dimensional Spheroid Configurations and Cellular Metabolic Properties of Oral Squamous Carcinomas Are Possible Pharmacological and Pathological Indicators.
Cancers (Basel)
; 15(10)2023 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345130
6.
Prognostic Value of CD45Ro+ T-Cell Expression in Patients With Oral Squamous Cell Carcinoma.
Anticancer Res
; 41(9): 4515-4522, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34475077
7.
Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma.
PLoS One
; 15(8): e0237465, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785290
8.
Borderline Microenvironment Fibrosis Is a Novel Poor Prognostic Marker of Oral Squamous Cell Carcinoma.
Anticancer Res
; 40(8): 4319-4326, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727759